GeneDx Holdings Corp. (NASDAQ: WGS) Securities Fraud Class Action

Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired GeneDx Holdings Corp. (“GeneDx”) (NASDAQ: WGS) common stock between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”).

GeneDx provides genetic testing services for diagnosing pediatric and rare diseases. The class period begins on April 16, 2025, when GeneDx announced that it entered into an agreement worth up to $51 million to acquire Fabric Genomics (“Fabric”), a firm focused on AI-driven genomic interpretation. As part of the deal, WGS would pay up to $33 million cash up front, with total consideration up to $51 million. As part of the announcement of the acquisition, GeneDx stated that it would expand Gene DX’s addressable market with several scalable revenue streams. GeneDx went on to tout that Fabric’s software transforms static data into a dynamic, recurring revenue-generating platform—driving growth through software margins and high-leverage interpretation services across geographies and clinical use cases.”

When the acquisition was completed on May 5, 2025, GeneDx CEO Katherine Stueland (“Stueland”) again highlighted that this acquisition would “unlock recurring software based revenue streams through Fabric’s interpretation as-a-service model.” During the Q2 2025 earnings call on July 29, 2025, Stueland again stated that the company’s market lead would only continue to expand as we integrate Fabric Genomics and its proprietary algorithms into the core platform, further strengthening our competitive edge and positioning us for unprecedented scale.”

The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material facts about the company’s business, operations, and prospects. Specifically, Defendants misrepresented and/or failed to disclose that: (1) Fabric faced significant problems with its viability; and (3) as a result of the foregoing, Defendants’ statements about the company’s business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Current Status of Case:
On August 3, 2026, Motions to Appoint Lead Plaintiff and Lead Counsel were filed. This action is ongoing.

If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at [email protected]. If you would like additional information about the suit, please click on the link “Submit Your Information” above and fill out the form as promptly as possible.

ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP:
Kessler Topaz Meltzer & Check, LLP (KTMC) is a leading U.S. plaintiff-side law firm focused on securities-fraud class actions and global investor protection. The firm represents individual investors as well as institutions, such as major pension funds, asset managers, and international investors. KTMC has led some of the largest recoveries in securities litigation and has been recognized by peers and the legal media with numerous accolades, including The National Law Journal’s Plaintiff’s Hot List and Trailblazers in Plaintiffs’ Law, BTI Consulting Group’s Honor Roll of Most Feared Law Firms, The Legal Intelligencer’s Class Action Firm of the Year, Lawdragon’s Leading Plaintiff Financial Lawyers, and Law360’s Titans of the Plaintiffs Bar. The firm operates globally with offices in Pennsylvania and California. KTMC has recovered over $25 billion for our clients and the classes they represent.